BrainsWay Ltd. BWAY
11.64 USD +0.49 (+4.39%)
At closeNov 9, 2026, 4:00 PM EST
11.64 0.00 0.00%
After hours · Nov 9, 4:00 PM ET
11.40 Day range 12.25
7.14 52-week range 17.40
- YTD
- +22.40%
- 1 year
- +49.23%
News
benzinga.com BrainsWay Partners With Mindful Health Solutions To Pursue Strategic Initiatives To Expand Patient Access To Health Treatments BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced a strategic- benzinga.com HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $19 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $19 price target.
benzinga.com BrainsWay, Inland Psychiatric Collaborate On Multi-System Deep TMS Deployment And Mental Health Research Initiatives BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced non-invasive neurostimulation treatments for mental health disorders, today announced a strategic
benzinga.com Bumble, Fermi, Xtend AI Robotics And Other Big Stocks Moving Higher On Tuesday U.S. stocks mostly fell; Bumble surged 56.7% on Ithaca’s $6.05 buyout offer, while Fermi, Enerflex, BigBear.ai and others gained.
benzinga.com HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $19 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $19 price target.
benzinga.com Snowflake To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Monday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BMO…- benzinga.com HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $19 HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $17 to $19.
- benzinga.com Ladenburg Thalmann Maintains Buy on BrainsWay, Raises Price Target to $18.8 Ladenburg Thalmann analyst Jeffrey Cohen maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $18 to $18.8.
benzinga.com BrainsWay Raises FY2026 Sales Guidance from $66.000M-$68.000M to $68.000M-$70.000M vs $67.819M Est BrainsWay (NASDAQ:BWAY) raises FY2026 sales outlook from $66.000 million-$68.000 million to $68.000 million-$70.000 million vs $67.819 million estimate.- benzinga.com BrainsWay Q2 EPS $0.07 Misses $0.08 Estimate, Sales $17.107M Beat $16.497M Estimate BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.08 by 12.5 percent. This is a 40 percent increase over earnings of $0.05 per…
- benzinga.com BTIG Initiates Coverage On BrainsWay with Buy Rating, Announces Price Target of $18 BTIG analyst Sam Eiber initiates coverage on BrainsWay (NASDAQ:BWAY) with a Buy rating and announces Price Target of $18.
- benzinga.com BrainsWay To Invest $500,000 For Minority Position In Sound Minds In The Form Of Preferred, Annually Compounding Security BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced its participation
- benzinga.com HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $17 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $17 price target.
benzinga.com BrainsWay Presents New Data On Enhancements In Participants With Comorbid Post-Traumatic Stress Disorder, Major Depressive Disorder With Deep Transcranial Magnetic Stimulation BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies, today announced the presentation of positive new
benzinga.com BrainsWay Expands Insurance Coverage for Faster Depression Treatment BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies, today announced further expansion in the number of medical- benzinga.com HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $17 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $17 price target.
benzinga.com BrainsWay Presents New Prospective 12-Month Durability Data Demonstrating Sustained Clinical Benefits Following Accelerated Deep Transcranial Magnetic Stimulation For Major Depressive Disorder BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the presentation of new prospective 12-month durability data…- benzinga.com HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $17 HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $15 to $17.
benzinga.com BrainsWay To Invest $1.5M Initially, With Potential For Additional $1.5M Via Milestone-Based Investments, For Minority Position In Hopemark In Form Of Preferred, Annually Compounding Security BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced it has entered…
benzinga.com Full Transcript: BrainsWay Q1 2026 Earnings Call - benzinga.com BrainsWay Affirms FY2026 Sales Guidance of $66.000M-$68.000M vs $66.350M Est BrainsWay (NASDAQ:BWAY) affirms FY2026 sales outlook from $66.000 million-$68.000 million to $66.000 million-$68.000 million vs $66.350 million estimate.
benzinga.com BrainsWay Q1 EPS $0.06 Beats $0.05 Estimate, Sales $15.531M Beat $14.539M Estimate BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 20 percent. This is a 200 percent increase over earnings of $0.02 per…
benzinga.com Earnings Scheduled For May 13, 2026 
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - benzinga.com BrainsWay Completes Additional $6M Milestone-Based Convertible Loan To Neurolief BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the completion of…
benzinga.com Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session Dow futures down 0.2%. Hesai Group -ADR shares drop 6.6% after reporting lower quarterly earnings and sales. Other stocks also down in pre-market.
benzinga.com Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session Dow futures down 0.2%. Hesai Group -ADR shares drop 6.6% after reporting lower quarterly earnings and sales. Other stocks also down in pre-market.- benzinga.com BrainsWay Completes $1M Investment In Axis Management BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it has…
benzinga.com Micron To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Thursday Top analysts change outlook on top names. HC Wainwright cut BWAY price target, Mizuho raised PENN target, Telsey slashed SFIX target, BTIG cut AVAV target, Barrington cut CURI target, Morgan Stanley…
benzinga.com HC Wainwright & Co. Maintains Buy on BrainsWay, Lowers Price Target to $15 HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and lowers the price target from $30 to $15.- benzinga.com Earnings Scheduled For March 11, 2026
benzinga.com Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 Health care sector has oversold stocks, RSI momentum indicator can help traders predict short term performance. Latest list of oversold players with RSI below 30: GOSS (26.3), BWAY (19.1), DH (20.2).
benzinga.com Molson Coors Beverage, Carvana, Avis Budget And Other Big Stocks Moving Lower In Thursday's Pre-Market Session 
benzinga.com Meta To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday 
benzinga.com Earnings Scheduled For November 11, 2025 - benzinga.com Earnings Scheduled For August 13, 2025
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Earnings Scheduled For May 13, 2025
- benzinga.com Earnings Scheduled For March 11, 2025
- benzinga.com Earnings Scheduled For November 12, 2024
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com Earnings Scheduled For March 6, 2024 Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com Earnings Scheduled For November 15, 2023 Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is likely to report earnings for its third quarter. • Movano (NASDAQ:MOVE) is projected to report earnings for its third…
- benzinga.com Earnings Scheduled For August 9, 2023 Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on revenue of $18.11 billion.
- benzinga.com Earnings Scheduled For May 17, 2023 Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is likely to report quarterly earnings at $0.14 per share on revenue of $369.35 million.
- benzinga.com Earnings Scheduled For March 15, 2023 Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
- benzinga.com Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
- benzinga.com Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
- benzinga.com Earnings Scheduled For November 16, 2022 Companies Reporting Before The Bell • Golden Ocean Group (NASDAQ:GOGL) is estimated to report earnings for its third quarter.